The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia
Clinical trial NCT02707497 · UNKNOWN
Trial details
- NCT number
- NCT02707497
- Sponsor
- Ruilan Wang
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2024-08-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.